This activity will delve into the lives of US Presidents with asthma, to draw a contrast between treatment approaches of the past and current and emerging therapies that target specific disease mechanisms. We’ll summarize mechanisms of action as well as key efficacy and safety data for cytokine antagonists being used or investigated for severe asthma treatment. The information learned will then be applied, using case scenarios, in selecting personalized treatments based on asthma phenotypes and endotypes.
MORE INFO (Agenda, Faculty and Learning Objectives)